+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Quinidine Sulfate Market - Global Forecast 2026-2032- Product Image
Quinidine Sulfate Market - Global Forecast 2026-2032- Product Image
New

Quinidine Sulfate Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 198 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5674748
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The quinidine sulfate market remains strategically important as clinical, regulatory, and supply chain considerations converge to influence access and patient outcomes. Senior decision-makers must navigate evolving therapeutic preferences, tightened regulatory scrutiny, and ongoing procurement complexities while ensuring safe and reliable delivery of this essential antiarrhythmic and antimalarial agent.

Market Snapshot: Quinidine Sulfate Market Growth and Dynamics

The Quinidine Sulfate Market grew from USD 708.99 million in 2025 to USD 740.95 million in 2026 and is projected to reach USD 1.07 billion by 2032 with a CAGR of 6.17%. Market expansion is driven by continued niche clinical roles, diversified sourcing strategies, and regional regulatory shifts. Competitiveness is shaped by both legacy suppliers and new entrants responding to escalated vigilance around safety, supply chain robustness, and optimized manufacturing practices.

Scope & Segmentation of the Quinidine Sulfate Market

  • Application Areas: Antiarrhythmic treatment for severe cardiac arrhythmias and antimalarial therapy in specific clinical contexts.
  • Dosage Forms: Availability in capsules, injectable solutions, and tablets, each demanding tailored manufacturing protocols and implementing form-specific stability or aseptic requirements.
  • Distribution Channels: Hospital pharmacy, online pharmacy, and retail pharmacy settings, with contrasting inventory management approaches and regulatory compliance needs.
  • End Users: Hospitals, clinics, and home healthcare environments, each shaping administration oversight, patient education strategies, and monitoring protocols.
  • Regions Covered: Americas, Europe, Middle East & Africa, and Asia-Pacific, each with unique regulatory, operational, and procurement dynamics.
  • Key Technologies: Modern manufacturing processes, robust quality control frameworks, advanced supply chain mapping, and pharmacovigilance systems for enhanced drug safety and production resilience.

Key Takeaways for Senior Stakeholders

  • Quinidine sulfate’s distinctive therapeutic profile sustains its use where alternative agents are unsuitable, requiring specialized governance and vigilant clinical protocols.
  • Safety concerns, such as QT interval prolongation and significant drug-drug interactions, necessitate centralized prescribing and enhanced monitoring by multidisciplinary teams.
  • Manufacturers increasingly diversify active pharmaceutical ingredient sourcing and reinforce quality systems to mitigate risks of supply disruption and regulatory noncompliance.
  • Procurement and clinical leaders must recalibrate strategies to address evolving regulatory requirements, risk communications, and periodic inspection schedules.
  • Organizations that foster collaboration between commercial, clinical, and supply chain disciplines are better positioned to absorb regulatory changes and operational challenges.

Tariff Impact: U.S. Trade Policy and Supply Economics

United States tariff measures through 2025 have added layers of cost and complexity to quinidine sulfate procurement. Manufacturers responded by reassessing supplier location strategies, accelerating nearshoring where feasible, and diversifying vendor portfolios to buffer tariff volatility. These shifts prompted distributors and healthcare providers to renegotiate contracts and enhance supply chain visibility, ensuring continued patient access despite operational frictions arising from regulatory schedules and production relocations.

Methodology & Data Sources

This report applies a mixed-methods research approach including thorough secondary regulatory documentation review, pharmacovigilance analysis, and in-depth interviews with clinicians, pharmacists, procurement directors, and supply chain managers. Data integrity was ensured through cross-validation across multiple independent sources, while transparency was maintained via documented interview sampling and source hierarchies to support actionable operational insights.

Why This Report Matters for Decision-Makers

  • Delivers fact-based analysis to support clinical, procurement, and regulatory strategies in the context of evolving market and policy environments.
  • Guides leaders in aligning stewardship programs, diversifying supply chain approaches, and mitigating operational or safety risks linked to quinidine sulfate.
  • Enables organizations to strengthen patient access and compliance by integrating regulatory intelligence, procurement best-practices, and contemporary pharmacovigilance frameworks.

Conclusion

Quinidine sulfate’s continued clinical relevance, paired with carefully managed supply partnerships and regulatory insight, ensures ongoing patient benefit and market stability. Success in this market depends on coordinated governance, supplier diversification, and vigilant clinical oversight.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Quinidine Sulfate Market, by Dosage Form
8.1. Capsules
8.2. Injectable
8.3. Tablets
9. Quinidine Sulfate Market, by Distribution Channel
9.1. Hospital Pharmacy
9.2. Online Pharmacy
9.3. Retail Pharmacy
10. Quinidine Sulfate Market, by End User
10.1. Clinics
10.2. Home Healthcare
10.3. Hospitals
11. Quinidine Sulfate Market, by Application
11.1. Arrhythmia Treatment
11.2. Malaria Treatment
12. Quinidine Sulfate Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Quinidine Sulfate Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Quinidine Sulfate Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Quinidine Sulfate Market
16. China Quinidine Sulfate Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Actiza Pharmaceutical Private Limited
17.6. Akhil Healthcare Private Limited
17.7. Alpspure Lifesciences Private Limited
17.8. Atra Pharmaceuticals Private Limited
17.9. Bennet Pharmaceuticals Ltd.
17.10. Buchler GmbH
17.11. Centurion Laboratories
17.12. Cipla Limited
17.13. Devlife Corporation Private Limited
17.14. Dwarkesh Pharmaceuticals Private Limited
17.15. Inga Laboratories Pvt. Ltd.
17.16. Ipca Laboratories Ltd.
17.17. Lark Laboratories Ltd.
17.18. Merck & Co., Inc.
17.19. Novartis AG
17.20. PMC Group, Inc.
17.21. Prism Industries Private Limited
17.22. Teva Pharmaceutical Industries Ltd.
17.23. USV Private Limited
17.24. Vivan Life Sciences Private Limited
List of Figures
FIGURE 1. GLOBAL QUINIDINE SULFATE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL QUINIDINE SULFATE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL QUINIDINE SULFATE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES QUINIDINE SULFATE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA QUINIDINE SULFATE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL QUINIDINE SULFATE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY ARRHYTHMIA TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY ARRHYTHMIA TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY ARRHYTHMIA TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY MALARIA TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY MALARIA TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY MALARIA TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. AMERICAS QUINIDINE SULFATE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 41. AMERICAS QUINIDINE SULFATE MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 42. AMERICAS QUINIDINE SULFATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 43. AMERICAS QUINIDINE SULFATE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 44. AMERICAS QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 45. NORTH AMERICA QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. NORTH AMERICA QUINIDINE SULFATE MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 47. NORTH AMERICA QUINIDINE SULFATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 48. NORTH AMERICA QUINIDINE SULFATE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 49. NORTH AMERICA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 50. LATIN AMERICA QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. LATIN AMERICA QUINIDINE SULFATE MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 52. LATIN AMERICA QUINIDINE SULFATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 53. LATIN AMERICA QUINIDINE SULFATE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 54. LATIN AMERICA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA QUINIDINE SULFATE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA QUINIDINE SULFATE MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA QUINIDINE SULFATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA QUINIDINE SULFATE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 60. EUROPE QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. EUROPE QUINIDINE SULFATE MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 62. EUROPE QUINIDINE SULFATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 63. EUROPE QUINIDINE SULFATE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 64. EUROPE QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 65. MIDDLE EAST QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. MIDDLE EAST QUINIDINE SULFATE MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 67. MIDDLE EAST QUINIDINE SULFATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 68. MIDDLE EAST QUINIDINE SULFATE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 69. MIDDLE EAST QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 70. AFRICA QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. AFRICA QUINIDINE SULFATE MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 72. AFRICA QUINIDINE SULFATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 73. AFRICA QUINIDINE SULFATE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 74. AFRICA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 75. ASIA-PACIFIC QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. ASIA-PACIFIC QUINIDINE SULFATE MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 77. ASIA-PACIFIC QUINIDINE SULFATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 78. ASIA-PACIFIC QUINIDINE SULFATE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 79. ASIA-PACIFIC QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. ASEAN QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. ASEAN QUINIDINE SULFATE MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 83. ASEAN QUINIDINE SULFATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 84. ASEAN QUINIDINE SULFATE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 85. ASEAN QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 86. GCC QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GCC QUINIDINE SULFATE MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 88. GCC QUINIDINE SULFATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 89. GCC QUINIDINE SULFATE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 90. GCC QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 91. EUROPEAN UNION QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. EUROPEAN UNION QUINIDINE SULFATE MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 93. EUROPEAN UNION QUINIDINE SULFATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 94. EUROPEAN UNION QUINIDINE SULFATE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 95. EUROPEAN UNION QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 96. BRICS QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. BRICS QUINIDINE SULFATE MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 98. BRICS QUINIDINE SULFATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 99. BRICS QUINIDINE SULFATE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 100. BRICS QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 101. G7 QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. G7 QUINIDINE SULFATE MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 103. G7 QUINIDINE SULFATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 104. G7 QUINIDINE SULFATE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 105. G7 QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 106. NATO QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. NATO QUINIDINE SULFATE MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 108. NATO QUINIDINE SULFATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 109. NATO QUINIDINE SULFATE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. NATO QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. UNITED STATES QUINIDINE SULFATE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 113. UNITED STATES QUINIDINE SULFATE MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 114. UNITED STATES QUINIDINE SULFATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 115. UNITED STATES QUINIDINE SULFATE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. UNITED STATES QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 117. CHINA QUINIDINE SULFATE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 118. CHINA QUINIDINE SULFATE MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 119. CHINA QUINIDINE SULFATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 120. CHINA QUINIDINE SULFATE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 121. CHINA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Quinidine Sulfate market report include:
  • Actiza Pharmaceutical Private Limited
  • Akhil Healthcare Private Limited
  • Alpspure Lifesciences Private Limited
  • Atra Pharmaceuticals Private Limited
  • Bennet Pharmaceuticals Ltd.
  • Buchler GmbH
  • Centurion Laboratories
  • Cipla Limited
  • Devlife Corporation Private Limited
  • Dwarkesh Pharmaceuticals Private Limited
  • Inga Laboratories Pvt. Ltd.
  • Ipca Laboratories Ltd.
  • Lark Laboratories Ltd.
  • Merck & Co., Inc.
  • Novartis AG
  • PMC Group, Inc.
  • Prism Industries Private Limited
  • Teva Pharmaceutical Industries Ltd.
  • USV Private Limited
  • Vivan Life Sciences Private Limited

Table Information

Report AttributeDetails
No. of Pages198
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 740.95 Million
Forecasted Market Value ( USD ) by 2032 $ 1070 Million
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Quinidine Sulfate - Global Strategic Business Report - Product Image

Quinidine Sulfate - Global Strategic Business Report

  • Report
  • 175 Pages
  • Global
From
Quinidine Sulfate (CAS 50-54-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Quinidine Sulfate (CAS 50-54-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Quinidine Sulfate Market 2026-2030 - Product Image

Quinidine Sulfate Market 2026-2030

  • Report
  • 276 Pages
  • Global
From
Quinidine Gluconate (CAS 7054-25-3) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Quinidine Gluconate (CAS 7054-25-3) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Vindesine Sulfate API Market - Global Forecast 2026-2032 - Product Image

Vindesine Sulfate API Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From

About the Quinidine Market

Quinidine is a medication used to treat irregular heartbeats, or arrhythmias. It is a type of antiarrhythmic drug, which works by blocking certain electrical signals in the heart that cause arrhythmias. Quinidine is used to treat atrial fibrillation, atrial flutter, and ventricular tachycardia. It is also used to treat certain types of supraventricular tachycardia, such as Wolff-Parkinson-White syndrome. Quinidine is available in both oral and injectable forms. Quinidine is a part of the larger cardiovascular drug market, which includes medications used to treat a variety of heart conditions. These drugs are used to treat high blood pressure, heart failure, and coronary artery disease, as well as arrhythmias. The cardiovascular drug market is highly competitive, with many different companies offering a variety of medications. Some of the companies in the quinidine market include Pfizer, Merck, GlaxoSmithKline, and Sanofi. These companies offer both generic and branded versions of quinidine, as well as other antiarrhythmic drugs. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.